{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:54Z","timestamp":1772165694769,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to investigate the expression characteristics of ANGPTL8 in patients with primary nephrotic syndrome and its possible correlation with hyperlipidemia and proteinuria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>ANGPTL8 levels were determined using an enzyme-linked immunosorbent assay in 133 subjects with PNS and 60 healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with healthy controls, subjects with primary nephrotic syndrome had higher levels of serum and urine ANGPTL8 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). In primary nephrotic syndrome patients, serum ANGPTL8 was positively correlated with cholesterol (r\u2009=\u20090.209,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) and triglycerides (r\u2009=\u20090.412,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), while there was no correlation with 24 hUTP. Urine ANGPTL8 was positively correlated with high-density lipoprotein cholesterol (r\u2009=\u20090.181,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05) and was significantly negatively correlated with creatinine (r\u2009=\u2009\u2212\u20090.323,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), eGFR (r\u2009=\u2009\u2212\u20090,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and 24 hUTP (r\u2009=\u2009\u2212\u20090.268,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002). Interestingly, the urine ANGPTL8 concentrations in membranous nephropathy and mesangial proliferative glomerulonephritis pathological types were different.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum and urine ANGPTL8 levels in primary nephrotic syndrome patients were correlated with blood lipid levels and proteinuria, respectively, suggesting that ANGPTL8 may play a role in the development of primary nephrotic syndrome hyperlipidemia and proteinuria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-021-02350-w","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T07:03:37Z","timestamp":1618383817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum and urine ANGPTL8 expression levels are associated with hyperlipidemia and proteinuria in primary nephrotic syndrome"],"prefix":"10.1186","volume":"22","author":[{"given":"Yue","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengdong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zichuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"issue":"8","key":"2350_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrneph.2012.115","volume":"8","author":"LA Greenbaum","year":"2012","unstructured":"Greenbaum LA, Benndorf R, Smoyer WE. Childhood nephrotic syndrome-current and future therapies. Nat Rev Nephrol. 2012;8(8):445\u201358. https:\/\/doi.org\/10.1038\/nrneph.2012.115.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"2350_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1056\/NEJM199008303230905","volume":"323","author":"J Joven","year":"1990","unstructured":"Joven J, Villabona C, Vilella E, Masana L, Albert\u00ed R, Vall\u00e9s M. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med. 1990;323(5):579\u201384. https:\/\/doi.org\/10.1056\/NEJM199008303230905.","journal-title":"N Engl J Med"},{"issue":"5","key":"2350_CR3","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1046\/j.1523-1755.2003.00941.x","volume":"63","author":"ND Vaziri","year":"2003","unstructured":"Vaziri ND. Molecular mechanisms of lipid disorders in nephrotic syndrome. Kidney Int. 2003;63(5):1964\u201376. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00941.x.","journal-title":"Kidney Int"},{"issue":"1","key":"2350_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneph.2015.180","volume":"12","author":"ND Vaziri","year":"2015","unstructured":"Vaziri ND. HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat Rev Nephrol. 2015;12(1):37.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"2350_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0014-5793(99)00008-3","volume":"443","author":"I Kim","year":"1999","unstructured":"Kim I, Kwak H, Ahn J, So J, Liu M, Koh K, et al. Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3. FEBS Lett. 1999;443(3):353\u20136. https:\/\/doi.org\/10.1016\/S0014-5793(99)00008-3.","journal-title":"FEBS Lett"},{"issue":"3","key":"2350_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/MOL.0000000000000290","volume":"27","author":"W Dijk","year":"2016","unstructured":"Dijk W, Kersten S. Regulation of lipid metabolism by angiopoietin-like proteins. Curr Opin Lipidol. 2016;27(3):249\u201356. https:\/\/doi.org\/10.1097\/MOL.0000000000000290.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"2350_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nm.2261","volume":"17","author":"LC Clement","year":"2011","unstructured":"Clement LC, Avila-Casado C, Mace C, Soria E, Bakker WW, Kersten S, et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med. 2011;17(1):117\u201322. https:\/\/doi.org\/10.1038\/nm.2261.","journal-title":"Nat Med"},{"issue":"9","key":"2350_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137049","volume":"10","author":"JS Li","year":"2015","unstructured":"Li JS, Chen X, Peng L, Wei SY, Zhao SL, Diao TT, et al. Angiopoietin-like-4, a potential target of tacrolimus, predicts earlier podocyte injury in minimal change disease. PLoS One. 2015;10(9):e0137049. https:\/\/doi.org\/10.1371\/journal.pone.0137049.","journal-title":"PLoS One"},{"issue":"6","key":"2350_CR9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/pr.2015.38","volume":"77","author":"JC Liu","year":"2015","unstructured":"Liu JC, Gao X, Zhai YH, et al. A novel role of angiopoietin-like-3 associated with podocyte injury [J]. Pediatr Res. 2015;77(6):732\u201329.","journal-title":"Pediatr Res"},{"issue":"8","key":"2350_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1440-1797.2012.01645.x","volume":"17","author":"H Liu","year":"2012","unstructured":"Liu H, Gao X, Xu H, et al. \u03b1-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury [J]. Nephrology. 2012;17(8):669\u201375. https:\/\/doi.org\/10.1111\/j.1440-1797.2012.01645.x.","journal-title":"Nephrology"},{"issue":"1","key":"2350_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbrc.2010.07.027","volume":"399","author":"X Gao","year":"2010","unstructured":"Gao X, Xu H, Liu H, Rao J, Li Y, Zha X. Angiopoietin-like protein 3 regulates the motility and permeability of podocytes by altering nephrin expression in vitro [J]. Biochem Biophys Res Commun. 2010;399(1):31\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2010.07.027.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"2350_CR12","first-page":"669","volume":"17","author":"L Jiaojiao","year":"2015","unstructured":"Jiaojiao L, Xu H, Rufeng D, Junchao L, Shen Q, Li S, et al. Potential function of angiopoietin-like protein 3 in hyperlipidemia of nephrotic syndrome. Chin J Nephrol. 2015;17(9):669\u201373.","journal-title":"Chin J Nephrol"},{"issue":"116","key":"2350_CR13","first-page":"1","volume":"18","author":"X Gao","year":"2019","unstructured":"Gao X, Suo YH, Zhang M, et al. Angiopoietin-like protein 3 markedly enhanced in the hyperlipidemia related proteinuria [J]. Lipids Health Dis. 2019;18(116):1\u20138.","journal-title":"Lipids Health Dis"},{"issue":"undefined","key":"2350_CR14","first-page":"23","volume":"5","author":"S Chugh","year":"2014","unstructured":"Chugh S, Mac\u00e9 C, Clement L, Nogal AMD, Marshall C. Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease. Front Pharmacol. 2014;5(undefined):23.","journal-title":"Front Pharmacol"},{"issue":"null","key":"2350_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000496799","volume":"103","author":"G Liu","year":"2019","unstructured":"Liu G, He L. Epigallocatechin-3-gallate attenuates adriamycin-induced focal segmental glomerulosclerosis via suppression of oxidant stress and apoptosis by targeting hypoxia-inducible factor-1\u03b1\/ angiopoietin-like 4 pathway. Pharmacology. 2019;103(null):303\u201314.","journal-title":"Pharmacology"},{"issue":"4","key":"2350_CR16","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.bbrc.2012.07.038","volume":"424","author":"R Zhang","year":"2012","unstructured":"Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012;424(4):786\u201392. https:\/\/doi.org\/10.1016\/j.bbrc.2012.07.038.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2350_CR17","doi-asserted-by":"publisher","first-page":"E334","DOI":"10.1152\/ajpendo.00084.2012","volume":"303","author":"G Ren","year":"2012","unstructured":"Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab. 2012;303(3):E334\u201351. https:\/\/doi.org\/10.1152\/ajpendo.00084.2012.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"2350_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.cell.2013.04.008","volume":"153","author":"P Yi","year":"2013","unstructured":"Yi P, Park JS, Melton D. Betatrophin: a hormone that controls pancreatic \u03b2 cell proliferation. Cell. 2013;153(2):747\u201358. https:\/\/doi.org\/10.1016\/j.cell.2013.04.008.","journal-title":"Cell"},{"issue":"10","key":"2350_CR19","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.molmet.2017.06.014","volume":"6","author":"X Chi","year":"2017","unstructured":"Chi X, Britt EC, Shows HW, Hjelmaas AJ, Shetty SK, Cushing EM, et al. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase [J]. Mol Metab. 2017;6(10):1137\u201349. https:\/\/doi.org\/10.1016\/j.molmet.2017.06.014.","journal-title":"Mol Metab"},{"issue":"4","key":"2350_CR20","doi-asserted-by":"publisher","first-page":"150272","DOI":"10.1098\/rsob.150272","volume":"6","author":"R Zhang","year":"2016","unstructured":"Zhang R. The ANGPTL3\u20134-8 model, a molecular mechanism for triglyceride trafficking. Open Biol. 2016;6(4):150272.","journal-title":"Open Biol"},{"issue":"7654","key":"2350_CR21","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/bmj.39576.709711.80","volume":"336","author":"RP Hull","year":"2008","unstructured":"Hull RP, Goldsmith DJA. Nephrotic syndrome in adults. BMJ. 2008;336(7654):1185\u20139. https:\/\/doi.org\/10.1136\/bmj.39576.709711.80.","journal-title":"BMJ"},{"issue":"10","key":"2350_CR22","first-page":"937","volume":"31","author":"Joint committee on revision of guidelines for prevention and treatment of dyslipidemia in China","year":"2016","unstructured":"Joint committee on revision of guidelines for prevention and treatment of dyslipidemia in China. The guidelines for prevention and treatment of dyslipidemia in Chinese adults. Chin Circul J. 2016;31(10):937\u201350.","journal-title":"Chin Circul J"},{"issue":"10","key":"2350_CR23","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1681\/ASN.2006040368","volume":"17","author":"YC Ma","year":"2006","unstructured":"Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937\u201344. https:\/\/doi.org\/10.1681\/ASN.2006040368.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2350_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Gipson DS, Hodson EM. Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol. 2013;28(3):415\u201326. https:\/\/doi.org\/10.1007\/s00467-012-2310-x.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"2350_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.ajkd.2014.04.016","volume":"64","author":"ND Vaziri","year":"2014","unstructured":"Vaziri ND, Moradi H. Dual role of circulating angiopoietin-like 4 (ANGPTL4) in promoting hypertriglyceridemia and lowering proteinuria in nephrotic syndrome. Am J Kidney Dis. 2014;64(4):495\u20138. https:\/\/doi.org\/10.1053\/j.ajkd.2014.04.016.","journal-title":"Am J Kidney Dis"},{"key":"2350_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.trsl.2017.03.001","volume":"184","author":"M Ejarque","year":"2017","unstructured":"Ejarque M, Borlaug M, Vilarrasa N, et al. Angiopoietin-like protein 8\/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery [J]. Transl Res. 2017;184:35\u201344.e34.","journal-title":"Transl Res"},{"issue":"1","key":"2350_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12933-015-0326-9","volume":"15","author":"C Chen","year":"2016","unstructured":"Chen C, Susanto H, Chuang W, Liu T, Wang C. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function. Cardiovasc Diabetol. 2016;15(1):3. https:\/\/doi.org\/10.1186\/s12933-015-0326-9.","journal-title":"Cardiovasc Diabetol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02350-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02350-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02350-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T19:58:07Z","timestamp":1618430287000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02350-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2350"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02350-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-129192\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of Gansu University of Traditional Chinese Medicine (No. syll20160037), and all methods were carried out in accordance with relevant guidelines and regulations. All participants gave their oral and written informed consent prior to participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients signed an informed consent from for the publication of their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}